ArticleCancer chemotherapy and pharmacology2018

A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc

Richard Greil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.